These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21887901)

  • 21. Bisphosphonate-induced osteonecrosis of the jaws: a challenge, a responsibility, and an opportunity.
    Marx RE
    Int J Periodontics Restorative Dent; 2008 Feb; 28(1):5-6. PubMed ID: 18351197
    [No Abstract]   [Full Text] [Related]  

  • 22. Is exposure of the jawbone mandatory for establishing the diagnosis of bisphosphonate-related osteonecrosis of the jaw?
    Yarom N; Fedele S; Lazarovici TS; Elad S
    J Oral Maxillofac Surg; 2010 Mar; 68(3):705. PubMed ID: 20171493
    [No Abstract]   [Full Text] [Related]  

  • 23. [Osteonecrosis of the jaw].
    Eriksen EF
    Ugeskr Laeger; 2009 Feb; 171(8):629; author reply 629. PubMed ID: 19291862
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravenous bisphosphonate treatment and osteonecrosis of the jaw in patients with cancer: wide CIs, Yule-Simpson and King Kong effects, and no therapeutic outcomes.
    Abraham I
    J Clin Oncol; 2010 Mar; 28(9):e143-4; author reply e145-7. PubMed ID: 20159796
    [No Abstract]   [Full Text] [Related]  

  • 25. Bisphosphonate medications--the good, the bad, and the ugly.
    Bourgeois SL
    Tex Dent J; 2009 Jul; 126(7):596-604. PubMed ID: 19753815
    [No Abstract]   [Full Text] [Related]  

  • 26. Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw.
    Wynn RL
    Gen Dent; 2005; 53(6):392-5. PubMed ID: 16366043
    [No Abstract]   [Full Text] [Related]  

  • 27. Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?
    Junquera L; Gallego L
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1516-7. PubMed ID: 18571043
    [No Abstract]   [Full Text] [Related]  

  • 28. American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition.
    Colella G; Campisi G; Fusco V
    J Oral Maxillofac Surg; 2009 Dec; 67(12):2698-9. PubMed ID: 19925998
    [No Abstract]   [Full Text] [Related]  

  • 29. Bisphosphonates, phossy jaw, and bisphosphonate-related osteonecrosis of the jaw.
    Lewis DM
    J Okla Dent Assoc; 2011; 102(5):36-9. PubMed ID: 21874699
    [No Abstract]   [Full Text] [Related]  

  • 30. Implications of bisphosphonate use for the dentist: an introduction.
    Kurtzman GM; Silverstein LH; Peden J; Shatz PC
    Dent Today; 2006 Jun; 25(6):80, 82-5; quiz 85. PubMed ID: 16792113
    [No Abstract]   [Full Text] [Related]  

  • 31. Horizons: the 2009 table clinics.
    Thumbigeremath V
    Northwest Dent; 2009; 88(3):33-4, 87. PubMed ID: 19691205
    [No Abstract]   [Full Text] [Related]  

  • 32. Osteonecrosis of the jaw.
    Sykes DL
    Dent Today; 2007 Feb; 26(2):16. PubMed ID: 17348272
    [No Abstract]   [Full Text] [Related]  

  • 33. Comprehensive review of bisphosphonate therapy: implications for the oral and maxillofacial surgery patient.
    Ruggiero SL; Carlson ER; Assael LA
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):1. PubMed ID: 19371808
    [No Abstract]   [Full Text] [Related]  

  • 34. Bisphosphonate-associated osteonecrosis: experiences in a private practice.
    Marder MZ; Marder RW
    Dent Today; 2008 Oct; 27(10):99-100, 102-3; quiz 103, 98. PubMed ID: 18935863
    [No Abstract]   [Full Text] [Related]  

  • 35. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases.
    Bagan JV; Jimenez Y; Murillo J; Hernandez S; Poveda R; Sanchis JM; Diaz JM; Scully C
    Oral Oncol; 2006 Mar; 42(3):327-9. PubMed ID: 16275156
    [No Abstract]   [Full Text] [Related]  

  • 36. Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
    Aragon-Ching JB; Dahut WL
    Oncologist; 2008 Dec; 13(12):1314; author reply 1315. PubMed ID: 19088325
    [No Abstract]   [Full Text] [Related]  

  • 37. Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces.
    Naik NH; Russo TA
    Clin Infect Dis; 2009 Dec; 49(11):1729-32. PubMed ID: 19886792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?
    Reid IR; Bolland MJ; Grey AB
    Bone; 2007 Sep; 41(3):318-20. PubMed ID: 17572168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bisphosphonate therapy and dental treatment.
    Phillips G
    J Indiana Dent Assoc; 2007-2008 Winter; 86(4):4-8. PubMed ID: 18363257
    [No Abstract]   [Full Text] [Related]  

  • 40. Bisphosphonates and osteonecrosis of the jaws.
    Mariotti A
    J Dent Educ; 2008 Aug; 72(8):919-29. PubMed ID: 18676801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.